Our latest news

Danvers, MA, USA, October 7, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the availability for purchase of GMP-grade recombinant monoclonal antibody conjugates targeting the G4S linker of scFv-based chimeric antigen receptors (CARs) for CAR-T cell enrichment and detection in cell therapy manufacturing […]

The Wittenstein Biointelligence Prize was awarded on Tuesday evening at the third Biointelligence Congress. Biotechnologist Moritz Bross won in the “Individual” category, while Cortical Labs was honored in the “Company” category. With this prize, the Wittenstein Foundation recognizes innovative, practical, and sustainable solutions that combine biology with information and production technology. Full Text in German […]

Just a few genetic changes transform simple RNA droplets into cell-like structures that can move and take up cargo A small number of random genetic mutations cause simple RNA droplets to transform into cell-like structures. In this process, they form cavities, can move and are able to take up cargo. This has been demonstrated through […]

by Sera Guli The latest release includes protein structure predictions for thousands of viruses, which could improve the response to future outbreaks AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database. To better understand and protect against emerging pathogens, the dataset prioritises proteomes from viral families known to […]

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]

It is no surprise that a healthy lifestyle can help reduce the risk of cancer. A large-scale analysis by researchers at the German Cancer Research Center (DKFZ) now confirms this association across a particularly broad spectrum of cancer types. The study also provides additional insights into several rarer and previously less-studied types of cancer. Not […]

CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking. A team led by scientists from the Heidelberg Faculty of Medicine at the Institute of Pathology of Heidelberg University Hospital, in […]

More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]